Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Loops01:01

Feedback Loops

63.3K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
63.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

779
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
779
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

6.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive arterial blood pressure waveform generation in critically ill patients: A sensor-based deep learning approach.

Computers in biology and medicine·2026
Same author

A Monte Carlo simulation based on first-passage distributions for spatio-temporal detection on potentiometric sensor arrays.

Analytical and bioanalytical chemistry·2026
Same author

Artificial intelligence for improving decision-making in bacterial infection management: a narrative review.

The Journal of antimicrobial chemotherapy·2025
Same author

The impact of artificial intelligence-driven decision support on uncertain antimicrobial prescribing: a randomised, multimethod study.

The Lancet. Digital health·2025
Same author

Sensitive near point-of-care detection of asymptomatic and submicroscopic Plasmodium falciparum infections in African endemic countries.

Nature communications·2025
Same author

Privacy Preserved Blood Glucose Level Cross-Prediction: An Asynchronous Decentralized Federated Learning Approach.

IEEE journal of biomedical and health informatics·2025

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.1K

Closed-loop bioelectronic medicine for diabetes management.

Amparo Güemes Gonzalez1, Ralph Etienne-Cummings2, Pantelis Georgiou1

  • 11Centre for Bio-Inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, London, UK.

Bioelectronic Medicine
|May 30, 2020
PubMed
Summary

Bioelectronic medicine uses electrical stimulation of nerves to treat diseases like diabetes. Closed-loop systems offer personalized, real-time therapies for better glucose control.

Keywords:
Bioelectronic medicineClosed-loop systemDiabetesNeuromodulationVagus nerve

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K
Revealing Electromechanical Control of Tissue Homeostasis Using a Two-Layer Microfluidic Device
11:08

Revealing Electromechanical Control of Tissue Homeostasis Using a Two-Layer Microfluidic Device

Published on: September 19, 2025

923

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.1K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K
Revealing Electromechanical Control of Tissue Homeostasis Using a Two-Layer Microfluidic Device
11:08

Revealing Electromechanical Control of Tissue Homeostasis Using a Two-Layer Microfluidic Device

Published on: September 19, 2025

923

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Endocrinology

Background:

  • The nervous system plays a crucial role in regulating glucose homeostasis.
  • Bioelectronic medicine leverages neural innervation for therapeutic interventions.
  • Electrical interfacing with peripheral nerves shows promise for managing diabetes.

Purpose of the Study:

  • To provide an overview of closed-loop neuromodulation systems for diabetes management.
  • To explore the potential of bioelectronic medicine in improving glucose control.
  • To discuss future opportunities in bioelectronic therapies for diabetes.

Main Methods:

  • Review of current research on closed-loop neuromodulation systems.
  • Analysis of bioelectronic medicine's application in regulating diabetes-related physiological processes (e.g., gastric emptying, insulin sensitivity, hormone secretion).
  • Discussion of novel closed-loop strategies for targeted neural interfacing.

Main Results:

  • Bioelectronic medicine offers a pathway for diagnosing and treating diabetes by interfacing with the nervous system.
  • Neuromodulation can influence key aspects of glucose regulation, including insulin sensitivity and hormone secretion.
  • Closed-loop systems enable autonomous, patient-specific therapies for chronic diseases like diabetes.

Conclusions:

  • Closed-loop bioelectronic medicine presents a promising frontier for real-time, personalized diabetes management.
  • Further research into neuromodulation systems can lead to advanced therapeutic strategies for diabetes.
  • The integration of neuroscience and engineering holds significant potential for treating metabolic disorders.